Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Tanmay Sahai"'
Publikováno v:
Case Reports in Oncological Medicine, Vol 2019 (2019)
We are reporting a case of a 30-year-old male with no past medical history who presented with new onset of renal failure, anemia, and splenomegaly and was diagnosed with multiple myeloma. Given the splenomegaly and the patient’s Jewish heritage, bl
Externí odkaz:
https://doaj.org/article/29aa711ca0ac46cd929634497d09fc8a
Publikováno v:
Case Reports in Transplantation, Vol 2018 (2018)
Externí odkaz:
https://doaj.org/article/2e1676886fbf4cb2beca0d4effbd8c98
Publikováno v:
Case Reports in Transplantation, Vol 2016 (2016)
Tacrolimus, a potent immunosuppressant medication, acts by inhibiting calcineurin, which eventually leads to inhibition of T-cell activation. The drug is commonly used to prevent graft rejection in solid organ transplant and graft-versus-host disease
Externí odkaz:
https://doaj.org/article/efc37b6517f749c19beac4341b452912
Autor:
Michael Wotman, Seungjun Ahn, Eun Jeong Oh, Amanda Wong, Daniel Zhu, Douglas Frank, Danielle Bottalico, Tristan Tham, Tanmay Sahai
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 166(6)
OBJECTIVE To investigate how differences in treatment parameters account for survival differences between races of patients with oropharyngeal squamous cell carcinoma (OPSCC). STUDY DESIGN Retrospective cohort study. SETTING National Cancer Database.
Publikováno v:
Laboratory medicine. 51(5)
Platelet-transfusion refractoriness (PTR) is common in patients with hematological malignancies. The etiology of immune PTR is typically human leukocyte antigen (HLA) antibodies (Abs) from pregnancy or previous transfusion. Herein, we report PTR in t
Publikováno v:
Transfusion. 57:1885-1890
BACKGROUND Patients on warfarin who present with bleeding or who require an urgent procedure are commonly treated with intravenous (IV) vitamin K, which is supplemented with repletion of the vitamin K factors using either plasma or a prothrombin comp
Publikováno v:
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine, Vol 2019 (2019)
Case Reports in Oncological Medicine, Vol 2019 (2019)
We are reporting a case of a 30-year-old male with no past medical history who presented with new onset of renal failure, anemia, and splenomegaly and was diagnosed with multiple myeloma. Given the splenomegaly and the patient’s Jewish heritage, bl
Autor:
Kelly F. Henrichs, Christopher T. Aquina, Amy E. Schmidt, Scott A. Kirkley, Debra Masel, Jane L. Liesveld, Neil Blumberg, Majed A. Refaai, Joanna M. Heal, Jason H. Mendler, Tanmay Sahai
Publikováno v:
Leukemia Research. 62:1-3
Despite dramatically improved long term outcomes seen with all-trans retinoic acid therapy, and now arsenic trioxide, in acute promyelocytic leukemia (APL), early mortality remains a substantial challenge. Recent data from a single center study and t
Publikováno v:
Case Reports in Transplantation
Case Reports in Transplantation, Vol 2016 (2016)
Case Reports in Transplantation, Vol 2016 (2016)
Tacrolimus, a potent immunosuppressant medication, acts by inhibiting calcineurin, which eventually leads to inhibition of T-cell activation. The drug is commonly used to prevent graft rejection in solid organ transplant and graft-versus-host disease
Publikováno v:
Transfusion. 57(8)
Patients on warfarin who present with bleeding or who require an urgent procedure are commonly treated with intravenous (IV) vitamin K, which is supplemented with repletion of the vitamin K factors using either plasma or a prothrombin complex concent